seed
Stage
3
Investors
About
Atlanthera is a biotechnology company that develops new treatments for bone and joint diseases such as osteosarcoma, bone metastases, arthritis, and osteomyelitis. The company uses innovative drug delivery systems to target active ingredients directly to bone and joint tissues, reducing systemic adverse effects.
Explore ATLANTHERA's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.